News for 'diabetes'

Can Skipping Breakfast Make You Diabetic?

Can Skipping Breakfast Make You Diabetic?

Rediff.com16 Oct 2025

Skipping breakfast can lead to insulin resistance and overeating later, warns rediffGURU Komal Jethmalani, a nutritionist with over 26 years of experience.

Weight Loss Drugs May Alter Your Brain

Weight Loss Drugs May Alter Your Brain

Rediff.com12 May 2026

A new study suggests that newer oral weight loss drugs may do more than suppress appetite, potentially altering brain circuits that control motivation and reward, impacting how one experiences pleasure.

Belagavi Court Remands Ponzi Scheme Accused To Custody

Belagavi Court Remands Ponzi Scheme Accused To Custody

Rediff.com18 May 2026

A Belagavi court has remanded Shivaanand Neelannavar, the alleged kingpin of a multi-crore ponzi scheme, to 10 days of CID custody for further investigation. The case involves an alleged fraud of nearly Rs 1,000 crore and affects around 35,000 investors.

'Son Addicted To Phone, Can Yoga Help?

'Son Addicted To Phone, Can Yoga Help?

Rediff.com3 Jun 2026

rediffGURU Pushpa R, founder of Radiant Yoga Vibes recommends simple exercises you can do from home to recover from pain, lose weight and heal naturally.

10 Things That Originated In India

10 Things That Originated In India

Rediff.com21 May 2026

Do you know some of the thoughts, ideas, disciplines and items India has given the world?

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Rediff.com8 Apr 2026

Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.

Silent Diseases Hit Young India

Silent Diseases Hit Young India

Rediff.com16 Apr 2026

Young adults show alarming NCD trends, with high rates of obesity, prediabetes, and abnormal cholesterol levels.

Murder Accused Allegedly Dies By Suicide In Jabalpur Jail

Murder Accused Allegedly Dies By Suicide In Jabalpur Jail

Rediff.com20 Apr 2026

A 60-year-old murder accused allegedly committed suicide inside a jail in Jabalpur, Madhya Pradesh, on Monday morning. The undertrial prisoner, Guddu alias Raja Vishwakarma, allegedly hanged himself using a towel in the bathroom of a hospital ward in the prison where he was being treated.

Hypertension in Army ranks at 9.61%, below national levels: Govt

Hypertension in Army ranks at 9.61%, below national levels: Govt

Rediff.com1 Apr 2026

A parliamentary panel has been informed that the prevalence of hypertension among Indian Army's junior commissioned officers and other ranks is lower than the national average, according to data up to December 31, 2023.

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Rediff.com9 Apr 2026

India's domestic pharmaceutical market recorded its highest value growth in five quarters during Q4 FY26, driven primarily by pricing and an early indication of volume recovery, with a significant structural shift towards chronic and sub-chronic therapies.

'My Father-In-Law's Death Saved Our Marriage'

'My Father-In-Law's Death Saved Our Marriage'

Rediff.com21 May 2026

Chitra tells us how her strained relationship with her husband and mother-in-law gradually improved after her father-in-law passed away.

PCOS Is Now PMOS: Why This Change Matters

PCOS Is Now PMOS: Why This Change Matters

Rediff.com14 May 2026

PCOS is being renamed PMOS. Dr Anagha Menon breaks down why the one alphabet change matters and how it affects the diagnosis of this condition for so many women.

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Biocon eyes in-licensing to boost biosimilars portfolio, targets margin expansion

Biocon eyes in-licensing to boost biosimilars portfolio, targets margin expansion

Rediff.com9 May 2026

Biocon is actively seeking in-licensing opportunities to expand its biosimilars portfolio, focusing on products that complement existing therapy areas, as the company shifts to a 'consolidate' phase with a strong emphasis on improving capacity utilisation, expanding margins, and driving return on capital employed.

Avoid These Life Insurance Mistakes

Avoid These Life Insurance Mistakes

Rediff.com8 May 2026

Proposal forms are often filled by the agent. Check the form after it is filled.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

What is Type 5 Diabetes?

What is Type 5 Diabetes?

Rediff.com16 May 2025

'Everyone with a low BMI will not get Type 5 diabetes.'

Over 45? You Might Have Diabetes And Not Know It

Over 45? You Might Have Diabetes And Not Know It

Rediff.com8 Aug 2025

Nearly one in five older Indians are affected by diabetes with many remaining unaware that they have the disease.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Heart Disease Risk Calculators Inadequate for Indian Population, Study Finds

Heart Disease Risk Calculators Inadequate for Indian Population, Study Finds

Rediff.com4 Apr 2026

A new study reveals that widely used heart disease risk calculators may not accurately identify Indians at risk, potentially leading to underestimation of risk and delayed treatment.

Fake Life-Saving Drugs Racket Busted in Delhi

Fake Life-Saving Drugs Racket Busted in Delhi

Rediff.com5 Apr 2026

Delhi Police have dismantled an organised interstate racket involved in manufacturing and distributing counterfeit life-saving medicines, arresting six individuals and seizing fake drugs worth approximately Rs 2 crore. The investigation also revealed a network of fake GST firms used for generating bogus invoices and laundering money.

Is Raw Sugar Better For Diabetics?

Is Raw Sugar Better For Diabetics?

Rediff.com23 Jun 2025

rediffGURU Komal Jethmalani, a dietician and nutritionist with over 27 years of experience, shares expert advice on weight loss and diabetes management.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Lancet Flags HbA1c Unreliability In Indians

Lancet Flags HbA1c Unreliability In Indians

Rediff.com9 Feb 2026

The Lancet study revealed that the HbA1c test is erroneous in populations with anemia and other hemoglobin-related deficiencies in India.

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Rediff.com17 Feb 2026

'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.

Delhi Man Shot Dead Over Parking Row: How It Happened

Delhi Man Shot Dead Over Parking Row: How It Happened

Rediff.com20 Apr 2026

A man was shot dead in Delhi's Preet Vihar following a parking dispute with a neighbour. The incident has left his pregnant wife and family in mourning.

Court Allows Lalu Aide Amit Katyal to Travel, Modifies Bail Terms in Money Laundering Case

Court Allows Lalu Aide Amit Katyal to Travel, Modifies Bail Terms in Money Laundering Case

Rediff.com16 Apr 2026

A Delhi court has granted Amit Katyal, a businessman linked to Lalu Prasad's family, permission to travel for religious purposes and modified his bail conditions in a money laundering case.

Why Insurance Claims Get Rejected

Why Insurance Claims Get Rejected

Rediff.com15 Apr 2026

'Many policyholders do not understand that non-medical expenses, cosmetic treatments, and certain other procedures are not covered by health insurance policies.'

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Can Women Over 40 Have A Normal Delivery?

Can Women Over 40 Have A Normal Delivery?

Rediff.com12 Mar 2026

While fertility does decline with age, many women have successfully delivered babies after the age of 40, notes Dr Rohan Palshetkar, consultant IVF specialist at Bloom IVF and Palshetkar Patil Nursing Home.

Weight Loss Drugs Set to Flood India

Weight Loss Drugs Set to Flood India

Rediff.com16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

Power Of Ginger: 10 Reasons Why It is Not Just A Spice

Power Of Ginger: 10 Reasons Why It is Not Just A Spice

Rediff.com2 Mar 2026

Anyone who has felt queasy, been sick, or had a unsettled tummy has likely tried ginger or been advised to do so. Ginger has been trusted for centuries as a gentle and reliable solution to many a medical ill.

How Sleep, Screen Time Affect Your Sex Life

How Sleep, Screen Time Affect Your Sex Life

Rediff.com11 Mar 2026

Burnout reduces pleasure, curiosity, and the ability to feel desire, even in healthy relationships.

212 Million Indians Have Diabetes

212 Million Indians Have Diabetes

Rediff.com14 Nov 2024

Of these 212 million Indians, 133 million have untreated diabetes. Undiagnosed diabetes has been linked with complications such as diabetic retinopathy which can cause vision loss and blindness.

What Foods Should Diabetics Eat?

What Foods Should Diabetics Eat?

Rediff.com8 Jan 2025

rediffGURU Rajiv Kovil, a senior diabetologist and obesity specialist, offers advice on how you can alter your diet and lifestyle to maintain healthy sugar levels.

New launches to keep growth momentum healthy for Sun Pharma stock

New launches to keep growth momentum healthy for Sun Pharma stock

Rediff.com13 Feb 2026

A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.

Ozempic launched in India, priced at Rs 2,200 per week

Ozempic launched in India, priced at Rs 2,200 per week

Rediff.com12 Dec 2025

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits.

9 Indian States With The Highest Incidence Of Diabetes

9 Indian States With The Highest Incidence Of Diabetes

Rediff.com3 Nov 2025

Diabetes cases across India have skyrocketed over the past 3 decades, climbing from 162 to 265 per lakh people between 1990 and 2021, marking an alarming 60 per cent rise.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'